0001593968-21-001140.txt : 20210421 0001593968-21-001140.hdr.sgml : 20210421 20210421181934 ACCESSION NUMBER: 0001593968-21-001140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210419 FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER ANDREW B CENTRAL INDEX KEY: 0001285221 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 21842690 BUSINESS ADDRESS: STREET 1: 440 CLYDE AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509305282 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-04-19 0000738214 AEMETIS, INC AMTX 0001285221 FOSTER ANDREW B 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 false true false false Executive Vice President Option (right to buy) 2.54 2021-04-19 4 D false 68000 18.6479 D 2016-08-19 2026-05-21 Common stock and Series B Preferred 78500 32000 D Option (right to buy) 1.72 2021-04-19 4 D false 90942 18.6479 D 2017-04-19 2027-01-19 Common stock and Series B Preferred 100000 9058 D Option (right to buy) 0.92 2021-04-19 4 D false 33304 18.6479 D 2019-09-06 2029-06-05 Common stock and Series B Preferred 35000 26696 D Option (right to buy) 0.86 2021-04-19 4 D false 39779 18.6479 D 2020-04-09 2030-01-09 Common stock and Series B Preferred 41666 60221 D Option (right to buy) 2.59 2021-04-19 4 D false 4138 18.6479 D 2016-03-10 2025-12-10 Common stock and Series B Preferred 20000 13134 D Option (right to buy) 2.59 2021-04-20 4 D false 10000 17.7075 D 2016-03-10 2025-12-10 Common stock and Series B Preferred 13134 3134 D 1/12th of the Option Shares vest every three(3)months from the date of the grant. The 1-19-2017 option grant was exercised and sold through 10b5-1 plan. The 1-19-2017 option grant was exercised and sold through 10b5-1 plan sold as below The 6-06-2019 option grant was exercised and sold through 10b5-1 plan. The 1-9-2020 option grant was exercised and sold through 10b5-1 plan. The shares were exercised from warrant grant 12/10/2015 and sold through executing the 10b5-1 plan. /s/Todd Waltz attorney-infact 2021-04-21